Associate Professor Phillip Stricker

Clinical Associate Professor
Surgery, Central Clinical School

Telephone 02 8382 6971

Map

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Selth, L., Townley, S., Bert, A., Stricker, P., Sutherland, P., Horvath, L., Goodall, G., Butler, L., Tilley, W. (2013). Circulating microRNAs predict biochemical recurrence in prostate cancer patients. British Journal of Cancer, 109(3), 641-650. [More Information]
  • Savdie, R., Horvath, L., Pe Benito, R., Rasiah, K., Haynes, A., Chatfield, M., Stricker, P., Turner, J., Delprado, W., Henshall, S., Kench, J., et al (2012). High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy. BJU International, 109(12), 1794-1800. [More Information]
  • Hossack, T., Patel, M., Huo, A., Brenner, P., Yuen, C., Spernat, D., Mathews, J., Haynes, A., Sutherland, R., Delprado, W., et al (2012). Location and Pathological Characteristics of Cancers in Radical Prostatectomy Specimens Identified by Transperineal Biopsy Compared to Transrectal Biopsy. The Journal of Urology, 188(3), 781-785. [More Information]
  • King, M., Viney, R., Smith, D., Hossain, I., Street, D., Savage, E., Fowler, S., Berry, M., Stockler, M., Cozzi, P., Armstrong, B., et al (2012). Survival gains needed to offset persistent adverse treatment effects in localised prostate cancer. British Journal of Cancer, 106(4), 638-645. [More Information]
  • Yip, P., Kench, J., Rasiah, K., Pe Benito, R., Lee, C., Stricker, P., Henshall, S., Sutherland, R., Horvath, L. (2011). Low AZGPI Expression Predicts for Recurrence in Margin-Positive, Localized Prostate Cancer. The Prostate, 71(15), 1638-1645. [More Information]
  • Talantov, D., Jatkoe, T., Bohm, M., Zhang, Y., Ferguson, A., Stricker, P., Kattan, M., Sutherland, R., Kench, J., Wang, Y., et al (2010). Gene based prediction of clinically localized prostate cancer progression after radical prostatectomy. The Journal of Urology, 184(4), 1521-1528. [More Information]
  • Bianco-Miotto, T., Chiam, K., Buchanan, G., Jindal, S., Day, T., Thomas, M., Pickering, M., O'Loughlin, M., Ryan, N., Raymond, W., Horvath, L., Kench, J., et al (2010). Global Levels of Specific Histone Modifications and an Epigenetic Gene Signature Predict Prostate Cancer Progression and Development. Cancer Epidemiology, Biomarkers and Prevention, 19(10), 2611-2622. [More Information]
  • Doumerc, N., Yuen, C., Savdie, R., Rahman, M., Pe Benito, R., Stricker, P. (2010). Robot-assisted Laparoscopic Prostatectomy: Analysis of An Experienced Open Surgeon's Learning Curve After 300 Procedures. Journal of Robotic Surgery, 3(4), 229-234. [More Information]
  • Doumerc, N., Yuen, C., Savdie, R., Rahman, M., Rasiah, K., Pe Benito, R., Delprado, W., Matthews, J., Haynes, A., Stricker, P. (2010). Should Experienced Open Prostatic Surgeons Convert to Robotic Surgery? The Real Learning Curve for One Surgeon over 3 Years. BJU International, 106, 378-384. [More Information]
  • Smith, D., King, M., Egger, S., Berry, M., Stricker, P., Cozzi, P., Ward, J., O'Connell, D., Armstrong, B. (2009). Quality of life three years after diagnosis of localised prostate cancer: population based cohort study. BMJ: British Medical Journal, 339, b4817-1-b4817-12. [More Information]
  • Ho, L., Kench, J., Handelsman, D., Scheffer, G., Stricker, P., Grygiel, J., Sutherland, R., Henshall, S., Allen, J., Horvath, L. (2008). Androgen regulation of multidrug resistance-associated protein 4 (MRP4/ABCC4) in prostate cancer. The Prostate, 68(13), 1421-1429. [More Information]
  • Kench, J., Rasiah, K., Gardiner-Garden, M., Padilla, E., Moller, G., Alles, M., Eggleton, S., Stricker, P., Adamski, J., Sutherland, R. (2008). HSD17B4 overexpression, an independent biomarker of poor patient outcome in prostate cancer. Molecular And Cellular Endocrinology, 301`, 89-96. [More Information]
  • Sakko, A., Butler, M., Byers, S., Reinboth, B., Stahl, J., Kench, J., Horvath, L., Sutherland, R., Stricker, P., Henshall, S., et al (2008). Immunohistochemical level of unsulfated chondroitin disaccharides in the cancer stroma is an independent predictor of prostate cancer relapse. Cancer Epidemiology, Biomarkers and Prevention, 17(9), 2488-2497. [More Information]
  • Rasiah, K., Kench, J., Gardiner-Garden, M., Biankin, A., Golovsky, D., Brenner, P., Kooner, R., O'Neill, G., Turner, J., Delprado, W., Lee, C., Horvath, L., et al (2006). Aberrant neuropeptide Y and macrophage inhibitory cytokine-1 expression are early events in prostate cancer development and are associated with poor prognosis. Cancer Epidemiology, Biomarkers and Prevention, 15(4), 711-716. [More Information]
  • Horvath, L., Henshall, S., Lee, C., Kench, J., Golovsky, D., Brenner, P., O'Neill, G., Kooner, R., Stricker, P., Grygiel, J., et al (2005). Lower levels of nuclear beta-catenin predict for a poorer prognosis in localized prostate cancer. International Journal of Cancer, 113(3), 415-422. [More Information]
  • Horvath, L., Henshall, S., Kench, J., Saunders, D., Lee, C., Golovsky, D., Brenner, P., O’Neill, G., Kooner, R., Stricker, P., et al (2004). Membranous Expression Of Secreted Frizzled-Related Protein 4 Predicts For Good Prognosis In Localized Prostate Cancer And Inhibits Pc3 Cellular Proliferation In Vitro. Clinical Cancer Research, 10(2), 615-625.
  • Afar, D., Bhaskar, V., Ibsen, E., Breinberg, D., Henshall, S., Kench, J., Drobnjak, M., Powers, R., Wong, M., Evangelista, F., et al (2004). Preclinical validation of anti-TMEFF2-auristatin E-conjugated antibodies in the treatment of prostate cancer. Molecular Cancer Therapeutics, 3(8), 921-932. [More Information]
  • Johnson, H., Weerakoon, P., Stricker, P. (2002). The incidence, aetiology and presentation of Peyronie's Disease in Sydney, Australia. Sexuality and Disability: a journal devoted to the psychological and medical aspects of sexuality in rehabilitation and community settings, 20(2), 109-116.
  • Lee, C., Henshall, S., Quinn, D., Head, D., Golovsky, D., Brenner, P., Delprado, W., Stricker, P., Grygiel, J., Sutherland, A. (2001). Altered Expression of Androgen Receptor in the Malignant Epithelium and Adjacent Stroma Is Associated with Early Relapse in Prostrate Cancer. Cancer Research, 61, 423-427.
  • Henshall, S., Quinn, D., Lee, C., Head, D., Golovsky, D., Brenner, P., Delprado, W., Stricker, P., Grygiel, J., Sutherland, R. (2001). Altered Expression of Androgen Receptor in the Malignant Epithelium and Adjacent Stroma Is Associated with Early Relapse in Prostrate Cancer. Cancer Research, 61, 5331-5335.

2013

  • Selth, L., Townley, S., Bert, A., Stricker, P., Sutherland, P., Horvath, L., Goodall, G., Butler, L., Tilley, W. (2013). Circulating microRNAs predict biochemical recurrence in prostate cancer patients. British Journal of Cancer, 109(3), 641-650. [More Information]

2012

  • Savdie, R., Horvath, L., Pe Benito, R., Rasiah, K., Haynes, A., Chatfield, M., Stricker, P., Turner, J., Delprado, W., Henshall, S., Kench, J., et al (2012). High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy. BJU International, 109(12), 1794-1800. [More Information]
  • Hossack, T., Patel, M., Huo, A., Brenner, P., Yuen, C., Spernat, D., Mathews, J., Haynes, A., Sutherland, R., Delprado, W., et al (2012). Location and Pathological Characteristics of Cancers in Radical Prostatectomy Specimens Identified by Transperineal Biopsy Compared to Transrectal Biopsy. The Journal of Urology, 188(3), 781-785. [More Information]
  • King, M., Viney, R., Smith, D., Hossain, I., Street, D., Savage, E., Fowler, S., Berry, M., Stockler, M., Cozzi, P., Armstrong, B., et al (2012). Survival gains needed to offset persistent adverse treatment effects in localised prostate cancer. British Journal of Cancer, 106(4), 638-645. [More Information]

2011

  • Yip, P., Kench, J., Rasiah, K., Pe Benito, R., Lee, C., Stricker, P., Henshall, S., Sutherland, R., Horvath, L. (2011). Low AZGPI Expression Predicts for Recurrence in Margin-Positive, Localized Prostate Cancer. The Prostate, 71(15), 1638-1645. [More Information]

2010

  • Talantov, D., Jatkoe, T., Bohm, M., Zhang, Y., Ferguson, A., Stricker, P., Kattan, M., Sutherland, R., Kench, J., Wang, Y., et al (2010). Gene based prediction of clinically localized prostate cancer progression after radical prostatectomy. The Journal of Urology, 184(4), 1521-1528. [More Information]
  • Bianco-Miotto, T., Chiam, K., Buchanan, G., Jindal, S., Day, T., Thomas, M., Pickering, M., O'Loughlin, M., Ryan, N., Raymond, W., Horvath, L., Kench, J., et al (2010). Global Levels of Specific Histone Modifications and an Epigenetic Gene Signature Predict Prostate Cancer Progression and Development. Cancer Epidemiology, Biomarkers and Prevention, 19(10), 2611-2622. [More Information]
  • Doumerc, N., Yuen, C., Savdie, R., Rahman, M., Pe Benito, R., Stricker, P. (2010). Robot-assisted Laparoscopic Prostatectomy: Analysis of An Experienced Open Surgeon's Learning Curve After 300 Procedures. Journal of Robotic Surgery, 3(4), 229-234. [More Information]
  • Doumerc, N., Yuen, C., Savdie, R., Rahman, M., Rasiah, K., Pe Benito, R., Delprado, W., Matthews, J., Haynes, A., Stricker, P. (2010). Should Experienced Open Prostatic Surgeons Convert to Robotic Surgery? The Real Learning Curve for One Surgeon over 3 Years. BJU International, 106, 378-384. [More Information]

2009

  • Smith, D., King, M., Egger, S., Berry, M., Stricker, P., Cozzi, P., Ward, J., O'Connell, D., Armstrong, B. (2009). Quality of life three years after diagnosis of localised prostate cancer: population based cohort study. BMJ: British Medical Journal, 339, b4817-1-b4817-12. [More Information]

2008

  • Ho, L., Kench, J., Handelsman, D., Scheffer, G., Stricker, P., Grygiel, J., Sutherland, R., Henshall, S., Allen, J., Horvath, L. (2008). Androgen regulation of multidrug resistance-associated protein 4 (MRP4/ABCC4) in prostate cancer. The Prostate, 68(13), 1421-1429. [More Information]
  • Kench, J., Rasiah, K., Gardiner-Garden, M., Padilla, E., Moller, G., Alles, M., Eggleton, S., Stricker, P., Adamski, J., Sutherland, R. (2008). HSD17B4 overexpression, an independent biomarker of poor patient outcome in prostate cancer. Molecular And Cellular Endocrinology, 301`, 89-96. [More Information]
  • Sakko, A., Butler, M., Byers, S., Reinboth, B., Stahl, J., Kench, J., Horvath, L., Sutherland, R., Stricker, P., Henshall, S., et al (2008). Immunohistochemical level of unsulfated chondroitin disaccharides in the cancer stroma is an independent predictor of prostate cancer relapse. Cancer Epidemiology, Biomarkers and Prevention, 17(9), 2488-2497. [More Information]

2006

  • Rasiah, K., Kench, J., Gardiner-Garden, M., Biankin, A., Golovsky, D., Brenner, P., Kooner, R., O'Neill, G., Turner, J., Delprado, W., Lee, C., Horvath, L., et al (2006). Aberrant neuropeptide Y and macrophage inhibitory cytokine-1 expression are early events in prostate cancer development and are associated with poor prognosis. Cancer Epidemiology, Biomarkers and Prevention, 15(4), 711-716. [More Information]

2005

  • Horvath, L., Henshall, S., Lee, C., Kench, J., Golovsky, D., Brenner, P., O'Neill, G., Kooner, R., Stricker, P., Grygiel, J., et al (2005). Lower levels of nuclear beta-catenin predict for a poorer prognosis in localized prostate cancer. International Journal of Cancer, 113(3), 415-422. [More Information]

2004

  • Horvath, L., Henshall, S., Kench, J., Saunders, D., Lee, C., Golovsky, D., Brenner, P., O’Neill, G., Kooner, R., Stricker, P., et al (2004). Membranous Expression Of Secreted Frizzled-Related Protein 4 Predicts For Good Prognosis In Localized Prostate Cancer And Inhibits Pc3 Cellular Proliferation In Vitro. Clinical Cancer Research, 10(2), 615-625.
  • Afar, D., Bhaskar, V., Ibsen, E., Breinberg, D., Henshall, S., Kench, J., Drobnjak, M., Powers, R., Wong, M., Evangelista, F., et al (2004). Preclinical validation of anti-TMEFF2-auristatin E-conjugated antibodies in the treatment of prostate cancer. Molecular Cancer Therapeutics, 3(8), 921-932. [More Information]

2002

  • Johnson, H., Weerakoon, P., Stricker, P. (2002). The incidence, aetiology and presentation of Peyronie's Disease in Sydney, Australia. Sexuality and Disability: a journal devoted to the psychological and medical aspects of sexuality in rehabilitation and community settings, 20(2), 109-116.

2001

  • Lee, C., Henshall, S., Quinn, D., Head, D., Golovsky, D., Brenner, P., Delprado, W., Stricker, P., Grygiel, J., Sutherland, A. (2001). Altered Expression of Androgen Receptor in the Malignant Epithelium and Adjacent Stroma Is Associated with Early Relapse in Prostrate Cancer. Cancer Research, 61, 423-427.
  • Henshall, S., Quinn, D., Lee, C., Head, D., Golovsky, D., Brenner, P., Delprado, W., Stricker, P., Grygiel, J., Sutherland, R. (2001). Altered Expression of Androgen Receptor in the Malignant Epithelium and Adjacent Stroma Is Associated with Early Relapse in Prostrate Cancer. Cancer Research, 61, 5331-5335.

To update your profile click here. For support on your academic profile contact .